Not applicableStudy completedNCT04830488What this trial is testingBody Image After Head and Neck Cancer TreatmentWho this might be right forHead and Neck Cancer Bethany Rhoten 7
Post-approval studies (Phase 4)Study completedNCT02622880What this trial is testingComparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer PatientsWho this might be right forHead and Neck Neoplasms Instituto de Investigación Hospital Universitario La Paz 68
Testing effectiveness (Phase 2)Study completedNCT00791141What this trial is testingAdjuvant Cetuximab and Chemoradiation in Head and Neck CancerWho this might be right forHead and Neck Cancer Heinrich-Heine University, Duesseldorf 80
Testing effectiveness (Phase 2)Study completedNCT00019331What this trial is testingVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsWho this might be right forColorectal CancerEndometrial CancerHead and Neck Cancer+6 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00524017What this trial is testingCetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive TractWho this might be right forHead and Neck CancerPrecancerous Condition Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Study completedNCT00588640What this trial is testingStudy of D-Methadone in Patients With Chronic PainWho this might be right forPainBladder CancerBreast Cancer+9 more Memorial Sloan Kettering Cancer Center 10
Not applicableEnded earlyNCT05061940What this trial is testingThis SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.Who this might be right forHead and Neck CancerMelanomaHPV-Related Malignancy+5 more Repertoire Immune Medicines 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Early research (Phase 1)Study completedNCT02537223What this trial is testingPhase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck CancerWho this might be right forSquamous Cell Carcinoma of Head and NeckLocoregionally Advanced University Health Network, Toronto 9
Not applicableLooking for participantsNCT07081074What this trial is testingROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck CancerWho this might be right forRadiation Dermatitis West China Hospital 40
Testing effectiveness (Phase 2)Study completedNCT04529850What this trial is testingPh 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck CancerWho this might be right forHead and Neck CancerOral Mucositis Galera Therapeutics, Inc. 38
Not applicableLooking for participantsNCT05808920What this trial is testingThe RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and NeckWho this might be right forHead and Neck Cancer Royal Marsden NHS Foundation Trust 400
Not applicableLooking for participantsNCT05483374What this trial is testingThe Head and Neck Registry of the European Reference Network on Rare Adult Solid CancersWho this might be right forHead and Neck CancerNasopharynx CancerNasal Cavity and Paranasal Sinus Cancer+2 more Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 13,600
Testing effectiveness (Phase 2)Ended earlyNCT00570674What this trial is testingAbraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and NeckWho this might be right forSquamous Cell Carcinoma of the Head and NeckBasaloid Squamous Cell CarcinomaUndifferentiated Carcinoma+1 more Dana-Farber Cancer Institute 29
Large-scale testing (Phase 3)Temporarily pausedNCT01810913What this trial is testingTesting Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerWho this might be right forOropharyngeal p16INK4a-Negative Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7+6 more National Cancer Institute (NCI) 613
Not applicableStudy completedNCT02879968What this trial is testingSerum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck CancerWho this might be right forHead and Neck Cancer Prince of Songkla University 52
Very early researchWithdrawnNCT04891718What this trial is testingCIVO Intratumoural Microdosing of Anti-Cancer Therapies in AustraliaWho this might be right forSolid Tumour Presage Biosciences
Early research (Phase 1)Study completedNCT04456140What this trial is testingPro-Active Genetic Testing in Patients With Solid Tumors, Inherit StudyWho this might be right forBreast CarcinomaDigestive System NeoplasmMalignant Brain Neoplasm+8 more Mayo Clinic 230
Not applicableEnded earlyNCT03402737What this trial is testingSBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&NWho this might be right forHead and Neck Neoplasm University Hospital, Ghent 6
Testing effectiveness (Phase 2)Ended earlyNCT02068157What this trial is testingInterstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck CancerWho this might be right forRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous CarcinomaRecurrent Lip and Oral Cavity Squamous Cell Carcinoma+4 more Roswell Park Cancer Institute 3